Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14293598 | 0.78 | CA1 (0.32) | CA1CA2CA9CA7 | |
| SCHEMBL15332020 | 0.77 | MAPT (0.36) | MAPTPOLBTDP1MEN1KMT2A | |
| SCHEMBL648441 | 0.77 | MAPT (0.39) | MAPTPOLBTDP1MEN1KMT2A | |
| SCHEMBL14585732 | 0.75 | CA1 (0.34) | CA1CA2CA9CA7POLB | |
| SCHEMBL604452 | 0.75 | — | — | |
| SCHEMBL12929803 | 0.75 | LMNA (0.37) | CA1CA2CA9MAPTMEN1 | |
| SCHEMBL21105290 | 0.74 | MAPT (0.34) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL21105282 | 0.74 | MAPT (0.31) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL21122902 | 0.74 | MAPT (0.34) | MAPTPOLBTDP1ALDH1A1NPSR1 | |
| SCHEMBL17847267 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115084655-A | Electrolyte, preparation method thereof and lithium metal battery containing electrolyte | 蜂巢能源科技(无锡)有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-115051032-A | Lithium ion battery electrolyte with negative electrode targeting passivation effect and preparation method thereof | 华中科技大学 | 2022-09-13 | — | — | CN | claimed |
| CN-113224386-B | Cobalt acid lithium battery electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2022-07-22 | — | — | CN | claimed |
| CN-114678532-A | Binder, preparation method thereof and electrochemical device comprising binder | 天目湖先进储能技术研究院有限公司 | 2022-06-28 | — | — | CN | claimed |
| CN-114552006-A | Electrolyte additive composition and application | 香河昆仑新能源材料股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| EP-3876329-A1 | ELECTROLYTE, ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE | Ningde Amperex Technology Limited (CN) | 2021-09-08 | — | — | EP | claimed |
| CN-113224386-A | Cobalt acid lithium battery electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2021-08-06 | — | — | CN | claimed |
| CN-111430794-B | Electrolyte, electrochemical device and electronic device | 宁德新能源科技有限公司 | 2021-06-29 | — | — | CN | claimed |
| US-20200388882-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FLUORINATED ELECTROLYTE FORMULATIONS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| CN-111430794-A | Electrolyte, electrochemical device and electronic device | 宁德新能源科技有限公司 | 2020-07-17 | — | — | CN | claimed |
| EP-4711389-A1 | METHOD FOR PRODUCING AQUEOUS FLUOROPOLYMER DISPERSION, AND AQUEOUS FLUOROPOLYMER DISPERSION | Daikin Industries, Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4707314-A2 | COMPOSITION AND METHOD FOR PRODUCING THE SAME | Daikin Industries, Ltd. (JP) | 2026-03-11 | — | — | EP | disclosed |
| EP-4685166-A2 | COMPOSITION AND METHOD FOR PRODUCING THE SAME | Daikin Industries, Ltd. (JP) | 2026-01-28 | — | — | EP | disclosed |
| EP-4026855-B1 | COMPOSITION AND METHOD FOR PRODUCING SAME | DAIKIN IND LTD (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-12531269-B2 | Silicon-based energy storage devices with fluorinated electrolyte formulations | ENEVATE CORPORATION (US) | 2026-01-20 | — | — | US | disclosed |
| US-20200388882-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FLUORINATED ELECTROLYTE FORMULATIONS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| CN-111430794-A | Electrolyte, electrochemical device and electronic device | 宁德新能源科技有限公司 | 2020-07-17 | — | — | CN | disclosed |
| US-7277218-B2 | Adding fluorinated polyether additive to a dispersion of electrophoretic pigment-containing microparticles dispersed in a dielectric solvent prepared by microencapsulation; improved colloidal stability, switching performance and temperature latitude | SIPIX IMAGING, INC. (US) | 2007-10-02 | — | — | US | disclosed |
| US-7105618-B2 | Fluorine-containing polymerizable monomers and polymers, anti-reflection film materials and resist compositions using same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2006-09-12 | — | — | US | disclosed |
| US-20030232940-A1 | Fluorine-containing polymerizable monomers and polymers, anti-reflection film materials and resist compositions using same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2003-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12531269-B2 | Silicon-based energy storage devices with fluorinated electrolyte formulations | SLC9A2, SLC9A1, HCN2 | CA1 53/4885CA2 4/4885CA9 79/4885 |
| US-20030232940-A1 | Fluorine-containing polymerizable monomers and polymers, anti-reflection film materials and resist compositions using same | AFF1, AFF4, AFF2 | CA1 917/4885CA2 2215/4885CA9 2502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.